To help handle all the new drugs that will be entering experimental tests on humans, Pfizer also recruited Briggs Morrison, who oversaw the oncology pipeline at Merck (nyse: MRK - news - people ) and was involved in a systematic review of Merck's clinical trials.
FORBES: Inside Out At Pfizer